查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1496005

全球果凍市場：2024-2029 年預測

Global Biosurgery Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 124 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

2022年果凍市場價值為121.14億美元，複合年成長率為6.70%，到2029年市場規模將達到190.77億美元。

果凍市場由用於最大限度地減少或減少術中和術後併發症的特定產品組成。果凍產品使手術和其他醫療程序更加高效且複雜。根據產品類型，果凍市場分為特定類型，如止血劑、抗沾黏劑、手術密封劑和骨移植替代品。

手術病例數量的增加和老年人口的增加為果凍產品的市場成長提供了潛力。 65歲以上人口和老年族群廣泛利用果凍產品的幫助和幫助。果凍產品在老年族群的醫療和外科手術中的廣泛應用正在增加全球市場對果凍產品的需求。此外，慢性病和運動手術導致的手術和外科手術病例數量的增加也推動了果凍市場的成長。

領先公司對果凍產品研發部門的投資增加也導致了這些產品的重大發展和進步。政府對果凍產品新的先進研究和開發的支持也推動了果凍產品市場的發展。醫療領域技術的發展和適應正在擴大果凍市場。

市場促進因素：

  • 不斷增加的研發計劃正在推動市場成長。

各大公司加大對果凍產品研發領域的投入，正在推動果凍市場的成長。技術和電子在果凍領域的滲透正在一定程度上推動果凍市場的成長。Medtronic公司開發的先進輸注骨移植技術被認為是骨移植植入和果凍產品領域的新發展之一。

美國對新開發的骨移植果凍的核准也顯示了該機構對食品藥物管理局產品開發的大力支持。 Kuros Biosurgery開發的合成水凝膠技術也是果凍市場的主要開拓之一。

果凍產品研發領域的快速成長正在推動果凍市場的成長。電子和新技術在醫療領域的日益滲透也帶來了果凍市場的新進展和開拓。主要公司在果凍產品研發領域的競爭日益激烈，推動了果凍產品在全球市場的快速成長。

  • 手術數量和慢性疾病患者的增加預計將急劇增加對果凍的需求。

手術數量的增加和慢性疾病患者數量的增加是推動果凍市場成長的主要因素。果凍產品提供的便利性和有效性正在導致果凍產品市場的成長。慢性病的增加也促進了果凍市場的成長。

心血管疾病（CVD）病例數量的增加以及果凍產品在心血管疾病手術和治療中的引入為果凍市場的成長提供了潛力。 CVD手術和移植是醫療領域廣泛應用果凍產品的主要領域。老年人口比例的增加也是果凍市場成長的主要驅動力之一。

據美國報告稱，全球約有9.62億人年齡在60歲以上。此外，據報道，60 歲及以上人口的人口成長率為每年 3%。老年人口的增加以及與文明病和慢性病的增加正在推動果凍市場的成長。

北美地區預計將引領市場。

從地理位置來看，北美地區預計將引領果凍市場。慢性病、文明病和肥胖問題的增加正在推動該地區果凍市場的成長。大公司的存在以及對果凍產品研發的投資也推動了北美地區果凍產品市場的發展。

北美以其先進的醫療基礎設施、技術進步、高昂的醫療成本、有利的法規環境、慢性病患病率不斷上升、主要市場參與者的強大影響力、臨床研究和學術合作以及先進的外科技術而聞名。

美國和加拿大擁有最先進的醫療設施、研究機構和醫療保健專業人員網路，為果凍市場的成長提供了有利的環境。該地區高昂的醫療成本、嚴格的 FDA 標準以及日益普及的慢性病都需要先進的外科干預措施，從而推動了北美對果凍解決方案的需求。該地區已準備好接受這些進步，因此處於果凍市場的前沿。

主要進展：

  • 2022 年 3 月 - Molecular Matrix, Inc. (MMI) 推出 Osteo-P(R)，這是一種用於肌肉骨骼系統的合成骨移植物 (BGS)。該技術採用 MMI 的超交聯碳水化合物聚合物 (HCCP) 平台，旨在最佳化骨骼修復和再生。 Osteo-P(R) BGS 有顆粒狀、立方體和條狀形式，是從傳統材料（如磷酸鈣和生物活性玻璃）骨移植物演變而來的。
  • 2022年2月 -GUNZE株式會社獲得日本首個吸收性防粘連材料“Tenaleaf（TM）”的製造和銷售核准。該產品是GUNZE利用其獨特的吸收材料技術開發的，旨在減少開放性手術和微創手術期間的術後器官粘連並改善患者的預後。該產品易於操作，具有適中的黏合強度，可以重新定位，使其成為不斷發展的腹腔鏡手術領域外科醫生的創新解決方案。

目錄

第1章簡介

  • 市場概況
  • 市場定義
  • 調查範圍
  • 市場區隔
  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關利益者的主要利益

第2章調查方法

  • 研究設計
  • 調查過程

第3章執行摘要

  • 主要發現

第4章市場動態

  • 市場促進因素
  • 市場限制因素
  • 波特五力分析
  • 產業價值鏈分析
  • 分析師觀點

第5章全球果凍市場：依產品類型

  • 介紹
  • 防沾黏劑
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 止血劑
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 手術密封劑
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 骨移植替代品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 軟組織附著
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第6章全球果凍市場：依應用分類

  • 介紹
  • 心臟血管/胸腔外科
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 神經脊椎手術
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 整形外科
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 一般外科
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 其他
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第7章 全球果凍市場：依來源分類

  • 介紹
  • 天然/生物來源製品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力
  • 合成產品
    • 市場機會和趨勢
    • 成長前景
    • 地域獲利能力

第8章全球果凍市場：按地區

  • 介紹
  • 北美洲
    • 依產品類型
    • 按用途
    • 按產地
    • 按國家/地區
  • 南美洲
    • 依產品類型
    • 按用途
    • 按產地
    • 按國家/地區
  • 歐洲
    • 依產品類型
    • 按用途
    • 按產地
    • 按國家/地區
  • 中東/非洲
    • 依產品類型
    • 按用途
    • 按產地
    • 按國家/地區
  • 亞太地區
    • 依產品類型
    • 按用途
    • 按產地
    • 按國家/地區

第9章競爭環境及分析

  • 主要企業及策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭對手儀表板

第10章 公司簡介

  • Baxter International Inc.
  • Johnson &Johnson
  • Becton, Dickinson and Company
  • B. Braun Melsungen AG
  • CryoLife, Inc.
  • Atrium Medical
  • Haemostasis LLC
  • Sanofi
  • Medtronic PLC
  • Kuros Bioscience
簡介目錄
Product Code: KSI061611887

The global biosurgery market is evaluated at US$12.114 billion for the year 2022, increasing at a CAGR of 6.70% to reach the market size of US$19.077 billion by the year 2029.

The global biosurgery market comprises certain products used to minimize or reduce intra- and post-surgery complications. Biosurgery products offer more efficiency and less complexity in surgery and other medical procedures. Depending on the types of products, the biosurgery market is segmented into certain types, such as hemostatic, anti-adhesive agents, surgical sealing agents, and bone graft substitutes.

The rising number of surgery cases and increasing geriatric population is giving potential to the market growth of global biosurgery products. The population aged 65 and above or the geriatric population is widely using the help and assistance of biosurgery products. The wide application of biosurgery products in medical and surgical procedures in the geriatric population raises the demand for biosurgery products in the global market. The rising cases of surgery and operation procedures due to chronic diseases and sports surgeries are also driving the global biosurgery market growth.

The higher investments by major companies in the research and development section of biosurgery products also result in major developments and advancements in these products. The government's support of new advanced research and developments in biosurgery products is also boosting the global biosurgery products market. The growth and adaptation of technology in the medical field increase the global biosurgery market.

Market Drivers:

  • Increasing research and development programs would bolster market growth.

The higher investments by major players or companies in the research and development sector of biosurgery products are boosting the global biosurgery market growth. The penetration of technology or electronics in the field of biosurgery has boosted the global biosurgery market growth to a certain extent. The development of advanced infused bone graft implantation developed by Medtronic PLC can be considered one of the rising developments in the field of bone graft implantation or biosurgery products.

The approval of the FDA (U.S Food and Drug Administration) for the newly developed bone graft implantation also shows the immense support of governmental agencies in the development of biosurgery products. The synthetic hydrogel technology developed by Kuros Biosurgery can also be counted as one of the major developments in the global biosurgery market.

The rapid growth in the research and development sector of biosurgery products is fuelling the global biosurgery market growth. The increased penetration of electronics and new technology in the medical field also resulted in new advancements and developments in the global biosurgery market. The higher competition of major players in the research and development sector of biosurgery products contributes to the rapid growth of biosurgery products in the global market.

  • A rising number of surgeries & cases of chronic diseases is anticipated to surge the biosurgery demand.

The rising number of surgeries and the increasing number of people with chronic diseases is one of the major factors driving the global biosurgery market growth. The convenience and effectiveness offered by biosurgery products result in the market growth of biosurgery products. The increasing cases of chronic diseases are contributing to the global biosurgery market growth.

The rising cases of cardiovascular diseases (CVDs) and the implementation of biosurgery products in surgeries and treatment of CVDs are giving potential to the global biosurgery market growth. The surgeries and implantations in CVDs are the major sections that widely employ the application of biosurgery products in the medical field. The rising percentage of the geriatric population is also one of the major driving factors in the global biosurgery market growth.

The report of the United Nations states that approximately 962 million people are aged 60 or above in the world. The population growth rate of people above 60 is also reported to be 3% annually. The rise in the geriatric population and increasing cases of lifestyle and chronic diseases are fuelling the global biosurgery market growth.

North America region is expected to lead the market.

Geographically, the North American region is expected to lead the global biosurgery market in the forecasted years. The rising cases of chronic and lifestyle diseases and obesity problems are driving the biosurgery market growth in this region. The presence of major players and the investment in research & development of biosurgery products are also hiking the market of biosurgery products in the North American region.

North America is expected to lead the global biosurgery market due to its advanced healthcare infrastructure, technological advancements, high healthcare expenditure, favorable regulatory environment, increasing prevalence of chronic diseases, strong presence of key market players, clinical research and academic collaboration, and early adoption of advanced surgical techniques.

The United States and Canada have state-of-the-art medical facilities, research institutions, and a network of healthcare professionals, providing a conducive environment for the biosurgery market growth. The region's high healthcare expenditure levels, stringent FDA standards, and increasing prevalence of chronic diseases necessitate advanced surgical interventions, thereby boosting the demand for biosurgery solutions in North America. The region's readiness to embrace these advancements positions it at the forefront of the global biosurgery market.

Key Developments:

  • March 2022- Molecular Matrix, Inc. (MMI) launched its Osteo-P(R) Synthetic Bone Graft Substitute (BGS) for use in the musculoskeletal system. The technology uses MMI's hyper-crosslinked carbohydrate polymer (HCCP) platform, designed to optimize bone repair and regeneration. Osteo-P(R) BGS available in granule, cube, and strip configurations and represents an evolution in bone grafting from traditional materials like calcium phosphate and bioactive glass. Its natural matrix doesn't require a collagen xenograft for better handling and offers real-time healing visualization through radiographic observation of calcium phosphate deposition.
  • February 2022- Gunze Limited obtained medical device approval to manufacture and sell TENALEAF(TM), the first sheet-type absorbable adhesion barrier made in Japan. The product, developed by Gunze using proprietary absorbable material technology, aims to reduce postoperative organ adhesions and improve patient outcomes during open and minimally invasive surgeries. The device allows easy manipulation, moderate adhesive strength for repositioning, and conformable placement, making it an innovative solution for surgeons in the growing field of laparoscopic surgery.

Segmentation:

By Product Type

  • Anti-adhesive agents
  • Hemostatic agents
  • Surgical sealing agents
  • Bone graft substitutes
  • Soft Tissue Attachments

By Application

  • Cardiovascular and Thoracic Surgery
  • Neuro-Spine surgery
  • Orthopedic Surgery
  • General Surgery
  • Others

By Source

  • Natural/Biological Products
  • Synthetic Products

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL BIOSURGERY MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Anti-adhesive agents
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. Hemostatic agents
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Surgical sealing agents
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Bone graft substitutes
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Soft Tissue Attachments
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL BIOSURGERY MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Cardiovascular and Thoracic Surgery
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Neuro-Spine surgery
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Orthopedic Surgery
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. General Surgery
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Others
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. GLOBAL BIOSURGERY MARKET BY SOURCE

  • 7.1. Introduction
  • 7.2. Natural/Biological Products
    • 7.2.1. Market Opportunities and Trends
    • 7.2.2. Growth Prospects
    • 7.2.3. Geographic Lucrativeness
  • 7.3. Synthetic Products
    • 7.3.1. Market Opportunities and Trends
    • 7.3.2. Growth Prospects
    • 7.3.3. Geographic Lucrativeness

8. GLOBAL BIOSURGERY MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By Source
    • 8.2.4. By Country
      • 8.2.4.1. USA
        • 8.2.4.1.1. Market Opportunities and Trends
        • 8.2.4.1.2. Growth Prospects
      • 8.2.4.2. Canada
        • 8.2.4.2.1. Market Opportunities and Trends
        • 8.2.4.2.2. Growth Prospects
      • 8.2.4.3. Mexico
        • 8.2.4.3.1. Market Opportunities and Trends
        • 8.2.4.3.2. Growth Prospects
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By Source
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
        • 8.3.4.1.1. Market Opportunities and Trends
        • 8.3.4.1.2. Growth Prospects
      • 8.3.4.2. Argentina
        • 8.3.4.2.1. Market Opportunities and Trends
        • 8.3.4.2.2. Growth Prospects
      • 8.3.4.3. Others
        • 8.3.4.3.1. Market Opportunities and Trends
        • 8.3.4.3.2. Growth Prospects
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By Source
    • 8.4.4. By Country
      • 8.4.4.1. Germany
        • 8.4.4.1.1. Market Opportunities and Trends
        • 8.4.4.1.2. Growth Prospects
      • 8.4.4.2. France
        • 8.4.4.2.1. Market Opportunities and Trends
        • 8.4.4.2.2. Growth Prospects
      • 8.4.4.3. UK
        • 8.4.4.3.1. Market Opportunities and Trends
        • 8.4.4.3.2. Growth Prospects
      • 8.4.4.4. Others
        • 8.4.4.4.1. Market Opportunities and Trends
        • 8.4.4.4.2. Growth Prospects
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By Source
    • 8.5.4. By Country
      • 8.5.4.1. Saudi Arabia
        • 8.5.4.1.1. Market Opportunities and Trends
        • 8.5.4.1.2. Growth Prospects
      • 8.5.4.2. UAE
        • 8.5.4.2.1. Market Opportunities and Trends
        • 8.5.4.2.2. Growth Prospects
      • 8.5.4.3. Others
        • 8.5.4.3.1. Market Opportunities and Trends
        • 8.5.4.3.2. Growth Prospects
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By Source
    • 8.6.4. By Country
      • 8.6.4.1. China
        • 8.6.4.1.1. Market Opportunities and Trends
        • 8.6.4.1.2. Growth Prospects
      • 8.6.4.2. India
        • 8.6.4.2.1. Market Opportunities and Trends
        • 8.6.4.2.2. Growth Prospects
      • 8.6.4.3. Japan
        • 8.6.4.3.1. Market Opportunities and Trends
        • 8.6.4.3.2. Growth Prospects
      • 8.6.4.4. South Korea
        • 8.6.4.4.1. Market Opportunities and Trends
        • 8.6.4.4.2. Growth Prospects
      • 8.6.4.5. Taiwan
        • 8.6.4.5.1. Market Opportunities and Trends
        • 8.6.4.5.2. Growth Prospects
      • 8.6.4.6. Thailand
        • 8.6.4.6.1. Market Opportunities and Trends
        • 8.6.4.6.2. Growth Prospects
      • 8.6.4.7. Indonesia
        • 8.6.4.7.1. Market Opportunities and Trends
        • 8.6.4.7.2. Growth Prospects
      • 8.6.4.8. Others
        • 8.6.4.8.1. Market Opportunities and Trends
        • 8.6.4.8.2. Growth Prospects

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Baxter International Inc.
  • 10.2. Johnson &Johnson
  • 10.3. Becton, Dickinson and Company
  • 10.4. B. Braun Melsungen AG
  • 10.5. CryoLife, Inc.
  • 10.6. Atrium Medical
  • 10.7. Haemostasis LLC
  • 10.8. Sanofi
  • 10.9. Medtronic PLC
  • 10.10. Kuros Bioscience